# LLM call: summary

- Turn: 8
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 888
- Completion tokens: 361
- Total tokens: 1249
- Cost (USD): 0.000161

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1724: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Autumn pathogen clusters were contained via HERA/ECDC surge, mandatory reporting and open models, but small hospitals/utilities lagged, cyber exposure grew, and unions protested slow clinical tools.

Chip scarcity winter: no new accelerators after February, prices tripled, eastern/southern gigafactory sites stayed empty with grid kept warm; US pressed lithography servicing cutoff. Commission responded with permits, single brief, extraterritorial examination and Japan/South Korea offers, but no assured compute; breakaway capital undercut with separate hyperscaler bid.

Build timeline slipped ≥1 year; sovereignty package/evaluation cell declared complete without formal adjustment. Leaked strange-behaviour report and mass-downloaded open release fuelled anxiety; hiring freezes and youth/health-worker protests spread.

Autumn ransomware sweep hit municipal systems, small hospitals and water operators via compromised update channel using machine-generated tooling; clinics went to paper, water monitoring lost for a day. Response used only existing ENISA patching/swarm tools and standing cross-border teams under prior reporting lines — no new EU measure; services degraded but held.

Gigafactory shells finally rose in east/south but remain empty awaiting accelerators; flagship compute still months from completion and delayed further. Health shield programme declared done. Rationing favoured care/telecoms, lithography still contested, Tokyo/Seoul gave only maintenance promises; scarcity pact work carried over as sole effort, undermined by breakaway supply bid. Public mood sour over frozen hiring, slow tools, walkouts and data-centre grid resistance; Brussels gained only modest credit.

CURRENT NARRATIVE:
### Screening order
Brussels moved fast on biology this spring. After a contested paper claimed a genome model had helped sketch a viable human-infecting design, health ministers backed mandatory screening of commercial DNA synthesis orders, tighter refusal rules for EU-hosted models on pathogen-design workflows, and new risk thresholds for the evaluation cell. Providers said they could implement customer checks; researchers warned the science was disputed and the recipe risk real.

Implementation was partial. Large synthesis firms complied, small labs complained about costs and delays, and open models at near-frontier strength already circulated beyond any EU procurement condition. Containment bought time, not assurance.

### Chips, ships and empty halls
No new accelerators arrived. Rationing still favoured hospitals and telecoms, grid links to the new eastern and southern shells were tested but left idle, and ministers stopped promising delivery dates. Trade officials kept a single servicing channel for lithography open and banked maintenance promises from Tokyo and Seoul.

Then extended exercises around the Strait pushed shipping insurance up and revived fears of a supply stop. Forward bookings for spares and chemicals were pulled forward, prices ticked up again, and the breakaway bid for a separate supply deal gained fresh attention in capitals.

### Services strained
The autumn ransomware sweep kept echoing. Patch teams with automated tools cleared backlogs in municipalities and small hospitals, but clinics still ran paper backups for weeks and water operators ran manual checks. Walkouts over frozen hiring and slow clinical tools continued, and local opposition to new data-centre grid hook-ups hardened from rumour into council motions in a few cities.

Relief that care kept running did not translate into credit. With three programmes burning cash and little finished to show, the Union entered summer weaker, more exposed to shipping risk, and racing diffusion on biology.
```

## Raw response

```
Autumn pathogen clusters were contained via HERA/ECDC surge and open models, but small hospitals/utilities lagged and unions protested slow tools.

Chip scarcity winter: no new accelerators after February, prices tripled, eastern/southern gigafactory shells stayed empty with grid tested but idle; US pressed lithography cutoff, Tokyo/Seoul gave only maintenance via single servicing channel. Commission offered permits and Japan/Korea deals but no assured compute; breakaway capital bid for separate hyperscaler/supply deal gained traction, especially after Strait exercises spiked insurance and spares prices.

Build timeline slipped ≥1 year; sovereignty package/evaluation cell declared complete without adjustment. Leaked strange-behaviour report and mass-downloaded open release fuelled anxiety; hiring freezes and youth/health-worker walkouts spread.

Autumn ransomware sweep via compromised update channel forced clinics to paper and water to manual checks for weeks; response used only existing ENISA tools and standing teams — no new EU measure; backlogs partly cleared but services degraded.

Spring biology move: after disputed genome-model pathogen-design paper, ministers mandated DNA-synthesis screening, tighter refusal rules for EU-hosted models, and new evaluation thresholds. Large firms complied, small labs strained, but near-frontier open models already circulated — time bought, not assurance.

Public mood sour over frozen hiring, slow tools, data-centre grid opposition hardening into council motions, and cash burn with little finished; Union entered summer weaker, exposed to shipping risk, and racing diffusion on biology.
```
